Skip to main content
. 2017 Jan 27;12:443–450. doi: 10.2147/COPD.S119390

Table 1.

Study subjects at baseline: demographics, severity of disease, and associated comorbidities

Population features 45–64 years
(n=2,537) (%)
65–74 years
(n=5,984) (%)
75–84 years
(n=11,817) (%)
≥85 years
(n=6,934) (%)
All patients
(n=27,272) (%)
Male gender 68.7 69.3 62.9 46.5 60.7
Severity score
 0 67.6 65.4 66.7 72.4 68.0
 1 29.7 30.6 29.4 25.2 28.6
 2 2.7 4.0 3.9 2.4 3.4
Modified Charlson index
 0 44.9 35.3 30.2 30.5 32.8
 1 35.2 36.9 39.1 40.6 38.6
 2 14.1 18.9 21.5 20.9 20.1
 ≥3 5.8 9.0 9.3 8.0 8.6
Selected comorbidities
 CKD 4.3 8.1 10.5 13.6 10.2
 Heart failure 11.9 18.9 26.1 32.6 24.9
 Ischemic heart disease 8.3 9.9 9.0 7.6 8.8
 Cerebrovascular diseases 4.5 8.1 11.3 12.3 10.2
 Peripheral arterial disease 6.0 8.6 8.5 5.4 7.5
 Diabetes 24.3 25.9 23.7 20.2 23.4
 Neoplasms 16.8 23.6 22.8 15.7 20.6
 Dementia 0.4 1.8 4.8 10.5 5.2
 Liver diseases 5.2 3.4 1.6 0.8 2.1
 Peptic ulcer 1.4 1.4 1.5 1.6 1.5
 Rheumatologic diseases 2.1 2.0 2.3 1.3 1.9

Notes: Severity score was defined by none, one, or both of the following criteria: a hospital diagnosis or an exemption from medical charges due to respiratory failure; previous hospitalizations for COPD. Modified Charlson index: the modified version of the Charlson Comorbidity Index (CCI) adapted to ICD-9-CM codes was adopted based on diseases reported during hospitalizations.

Abbreviations: CKD, chronic kidney disease; ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification.